Jai-Myung Yang

Title: Innovations of Jai-Myung Yang in Tumor-Specific Gene Regulation

Introduction

Jai-Myung Yang is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of gene regulation, particularly in the context of cancer research. His innovative work focuses on enhancing tumor-specificity and strength in transcriptional regulatory sequences.

Latest Patents

Jai-Myung Yang holds a patent for a "Modified tert promoter with enhanced tumor-specificity and strength and recombinant vector comprising the same." This invention relates to a transcriptional regulatory sequence that boasts enhanced tumor-specificity and strength, along with a recombinant vector that incorporates this sequence. Specifically, it involves a human telomere reverse transcriptase (hTERT) promoter linked to nucleotide sequences containing one or more c-Myc binding sites and/or Sp1 binding sites. This advancement has the potential to improve gene therapy approaches targeting tumors.

Career Highlights

Jai-Myung Yang is affiliated with Yonsei University, where he conducts research and develops innovative solutions in the field of molecular biology. His work has garnered attention for its potential applications in cancer treatment and gene therapy.

Collaborations

He collaborates with esteemed colleagues, including Chae-Ok Yun and Joo-Hang Kim, who contribute to his research endeavors and enhance the impact of his inventions.

Conclusion

Jai-Myung Yang's contributions to the field of gene regulation, particularly through his patented innovations, highlight his role as a key figure in cancer research. His work continues to pave the way for advancements in targeted therapies and molecular biology.